These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18368952)

  • 21. No deal in sight on cheap drugs for poor countries.
    Fleck F
    BMJ; 2003 Mar; 326(7387):465. PubMed ID: 12609924
    [No Abstract]   [Full Text] [Related]  

  • 22. [How important is prescription of generic preparations?].
    Cronlund A
    Lakartidningen; 2005 Aug 8-21; 102(32-33):2241. PubMed ID: 16145886
    [No Abstract]   [Full Text] [Related]  

  • 23. [Medication problems in connection with transferral between sectors].
    Christensen HR; Krølner BK
    Ugeskr Laeger; 2009 Mar; 171(10):808-11. PubMed ID: 19265608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost of preventive drugs. Dare to tell?
    Trewby PN
    BMJ; 2011 May; 342():d3198. PubMed ID: 21610062
    [No Abstract]   [Full Text] [Related]  

  • 25. [Scope of the contract for drug therapy. Rebate contracts also for original drugs].
    MMW Fortschr Med; 2009 Jul; 151(30-33):80. PubMed ID: 19722473
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical paternalism and expensive unsubsidised drugs.
    Jefford M; Savulescu J; Thomson J; Schofield P; Mileshkin L; Agalianos E; Zalcberg J
    BMJ; 2005 Nov; 331(7524):1075-7. PubMed ID: 16269497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness].
    Leutgeb R; Mahler C; Laux G; Weschnetz A; Szecsenyi J
    Dtsch Med Wochenschr; 2009 Jan; 134(5):181-6. PubMed ID: 19180404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adverse events related to substitution of generic products in Norway 2005].
    Reppe LA; Stenberg-Nilsen H; Harg P; Hegge AB; Lillefloth AK; Buajordet I
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2696-700. PubMed ID: 19079413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The price of success: cost-effectiveness of molecularly targeted agents.
    Sleijfer S; Verweij J
    Clin Pharmacol Ther; 2009 Feb; 85(2):136-8. PubMed ID: 19151639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Out-of-pocket and total costs of fixed-dose combination antihypertensives and their components.
    Rabbani A; Alexander GC
    Am J Hypertens; 2008 May; 21(5):509-13. PubMed ID: 18437141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescription drugs "The good--the bad--the ugly" and what you can do.
    Batterson RE;
    Tex Dent J; 2006 Apr; 123(4):384-5. PubMed ID: 16761653
    [No Abstract]   [Full Text] [Related]  

  • 33. Life-expectancy gains from pharmaceutical drugs: a critical appraisal of the literature.
    Lichtenberg FR
    Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):499-504; author reply 505-8. PubMed ID: 19941425
    [No Abstract]   [Full Text] [Related]  

  • 34. [Medical problems and risks of switching drugs according to legal requirements of drug discount contracts in Germany].
    Pruszydlo MG; Quinzler R; Kaltschmidt J; Haefeli WE
    Dtsch Med Wochenschr; 2008 Jul; 133(27):1423-8. PubMed ID: 18592450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A few specialty drug prices fall--all generics.
    Manag Care; 2008 Dec; 17(12):46. PubMed ID: 19127766
    [No Abstract]   [Full Text] [Related]  

  • 36. Lower your drug costs.
    Santa J
    Consum Rep; 2009 Jun; 74(6):13. PubMed ID: 19455768
    [No Abstract]   [Full Text] [Related]  

  • 37. [Important to keep the principle of value-based pricing of drugs].
    Persson U; Levin LA; Pettersson B
    Lakartidningen; 2009 Oct 28-Nov 3; 106(44):2862-4. PubMed ID: 19967967
    [No Abstract]   [Full Text] [Related]  

  • 38. Prescription drug spending: contribution to health care spending and cost containment strategies.
    Rivers PA; Hall NG; Frimpong J
    J Health Care Finance; 2006; 32(3):8-19. PubMed ID: 18975728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Payers struggle to ensure high level of adherence to costly specialty drugs.
    Sipkoff M
    Manag Care; 2008 Jul; 17(7):24-6, 29, 31. PubMed ID: 18757021
    [No Abstract]   [Full Text] [Related]  

  • 40. Internet drug access runs rampant.
    Scher CS; Torres A; Wieder SY
    Anesth Analg; 2007 Dec; 105(6):1868-9. PubMed ID: 18042903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.